Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility
{{output}}
Type 2 diabetes mellitus (T2DM) is a progressive disease characterized by insulin resistance, a steady decline in glucose-induced insulin secretion (most likely caused by a progressive decrease in functional beta-cell mass), and inappropriately regulated gluca... ...